Quantcast

Latest Panitumumab Stories

2008-06-30 12:03:15

Takeda Pharmaceutical and Takeda Bio Development Center have submitted a new drug application of anti-cancer agent, panitumumab for the treatment of patients with progressed or relapse colorectal cancer to the Ministry of Health Labour and Welfare in Japan.

2008-06-26 18:02:59

Amgen (NASDAQ: AMGN) today announced updated results from the "STEPP" (Skin Toxicity Evaluation Protocol with Panitumumab) trial, the first prospective study to examine differences between preemptive and reactive skin treatment for skin toxicities in metastatic colorectal cancer (mCRC) patients receiving epidermal growth factor receptor (EGFr) therapy.

2008-06-24 09:03:24

IRVING, Texas and PHOENIX, June 24 /PRNewswire/ -- Caris Diagnostics (Caris Dx), a leading provider of the highest quality diagnostic, translational development and pharmaceutical services encompassing anatomic pathology and molecular testing, announced that it is now offering KRAS mutation analysis, designed to provide information on which colon cancer patients are most likely to respond to cetuximab (Erbitux) co-marketed by ImClone and Bristol-Myers Squibb or panitumumab (Vectibix)...

2008-06-20 12:00:46

Merck KGaA has submitted an application to the European Medicines Agency to broaden the use of the targeted therapy Erbitux to include first-line treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck.

2006-06-12 15:51:28

LOS ANGELES (Reuters) - Biotechnology company Amgen Inc. said on Monday that the U.S. Food and Drug Administration has agreed to a "priority review" of the company's application for experimental drug panitumumab as a treatment for colon cancer.

2006-06-05 07:40:00

Using combinations of "smart bomb" cancer drugs that target specific proteins and avoid the indiscriminate cell destruction of chemotherapy may be the wave of the future for cancer patients, experts say.

2006-06-04 13:45:17

LOS ANGELES (Reuters) - Amgen Inc. said on Saturday that testing tumors for the protein that its experimental colon cancer drug panitumumab is designed to target is not an accurate measure of whether a patient will respond to the treatment.

2006-06-03 15:11:46

By Toni Clarke ATLANTA (Reuters) - Using combinations of "smart bomb" cancer drugs that target specific proteins and avoid the indiscriminate cell destruction of chemotherapy may be the wave of the future for cancer patients, experts say.

2006-04-03 13:25:12

By Megan Rauscher WASHINGTON (Reuters Health) - A

2005-11-03 14:13:13

CHICAGO (Reuters) - Amgen Inc. and Abgenix Inc. said on Thursday a late-stage study found its experimental drug panitumumab helped slow tumor progression in patients with advanced colon cancer who had failed multiple other therapies.


Word of the Day
chickabiddy
  • A young chicken: also used as a pet name for children.
The word 'chickabiddy' may come from 'chick' plus 'biddy', a name used in calling a hen or chicken.
Related